Skip NavigationSkip to Content

Crystal structure of the Schizosaccharomyces pombe U7BR E2-binding region in complex with Ubc7

  1. Author:
    Hann, Zachary S [ORCID]
    Metzger,Meredith [ORCID]
    Weissman,Allan [ORCID]
    Lima, Christopher D [ORCID]
  2. Author Address

    Structural Biology Program, Sloan Kettering Institute, 1275 York Avenue, New York, NY 10065, USA., Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.,
    1. Year: 2019
    2. Date: Aug 01
    3. Epub Date: 2019 08 02
  1. Journal: Acta crystallographica. Section F, Structural biology communications
    1. 75
    2. Pt 8
    3. Pages: 552-560
  2. Type of Article: Article
  1. Abstract:

    Endoplasmic reticulum (ER)-associated degradation (ERAD) is a protein quality-control pathway in eukaryotes in which misfolded ER proteins are polyubiquitylated, extracted and ultimately degraded by the proteasome. This process involves ER membrane-embedded ubiquitin E2 and E3 enzymes, as well as a soluble E2 enzyme (Ubc7 in Saccharomyces cerevisiae and UBE2G2 in mammals). E2-binding regions (E2BRs) that recruit these soluble ERAD E2s to the ER have been identified in humans and S. cerevisiae, and structures of E2-E2BR complexes from both species have been determined. In addition to sequence and structural differences between the human and S. cerevisiae E2BRs, the binding of E2BRs also elicits different biochemical outcomes with respect to E2 charging by E1 and E2 discharge. Here, the Schizosaccharomyces pombe E2BR was identified and purified with Ubc7 to resolve a 1.7 Å resolution co-crystal structure of the E2BR in complex with Ubc7. The S. pombe E2BR binds to the back side of the E2 as an a-helix and, while differences exist, it exhibits greater similarity to the human E2BR. Structure-based sequence alignments reveal differences and conserved elements among these species. Structural comparisons and biochemistry reveal that the S. pombe E2BR presents a steric impediment to E1 binding and inhibits E1-mediated charging, respectively. open access.

    See More

External Sources

  1. DOI: 10.1107/S2053230X19009786
  2. PMID: 31397327
  3. PII : S2053230X19009786

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel